Teradyne Story

<div class='circular--portrait' style='background:#169D0B;color: #E6E6FA;font-size:4em;'>TE</div>
TER -- USA Stock  

USD 125.64  8.55  6.37%

Let's try to sum up what's happening with Teradyne amid unprecedented political, and economic uncertainty. On the 26th of January the company is traded for 138.54. Teradyne has historical hype elasticity of -0.41. The average price elasticity to hype of competition is about 1.57. The entity is anticipated to decline in value after the next headline, with the price expected to drop to 139.38. The average volatility of media hype impact on Teradyne stock price is huge, making predictions on the news or social media along less reliable. The price depreciation on the next news is expected to be -0.29%, whereas the daily expected return is at this time at 0.83 percent. The volatility of related hype on Teradyne is about 104.87% with expected price after next announcement by competition of 140.11 Considering the 30-days investment horizon the next anticipated press release will be in about 10 days.
Published over three weeks ago
View all stories for Teradyne | View All Stories
Is Teradyne (NASDAQ:TER) gaining more confidence from retail investors?
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Teradyne has an asset utilization ratio of 158.93 percent. This connotes that the company is making $1.59 for each dollar of assets. An increasing asset utilization means that Teradyne is more efficient with each dollar of assets it utilizes for everyday operations. About 99.0% of the company shares are owned by institutional investors. Teradyne has Price/Earnings To Growth (PEG) ratio of 1.26. The entity last dividend was issued on the 24th of November 2020. The firm had 2:1 split on the 1st of September 1999.
The successful prediction of Teradyne stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Teradyne, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Teradyne based on Teradyne hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Teradyne's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Teradyne's related companies.

Use Technical Analysis to project Teradyne expected Price

Teradyne technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Teradyne technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Teradyne trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Teradyne, but it might be worth checking our own buy vs. sell analysis

Is Teradyne valued sensibly by the market?

The company reported the last year's revenue of 3.02 B. Total Income to common stockholders was 712.89 M with profit before taxes, overhead, and interest of 1.34 B.

Deferred Revenue Breakdown

Teradyne Deferred Revenue yearly trend continues to be relatively stable with very little volatility. Deferred Revenue is likely to drop to about 65.6 M. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. Teradyne Deferred Revenue is relatively stable at the moment as compared to the past year. Teradyne reported last year Deferred Revenue of 76.97 Million
201078.67 Million
201181.36 Million
201355.4 Million
201471.6 Million
201585.53 Million
202076.97 Million
202165.57 Million

Will Teradyne price fall impact its balance sheet?

Teradyne latest maximum drawdown advances over 10.62. Teradyne has relatively low volatility with skewness of 0.51 and kurtosis of 0.61. However, we advise all investors to independently investigate Teradyne to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns.

Our Final Takeaway

While other entities in the semiconductor equipment & materials industry are either recovering or due for a correction, Teradyne may not be performing as strong as the other in terms of long-term growth potentials. The inconsistency in the assessment between current Teradyne valuation and our trade advice on Teradyne is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Teradyne.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Teradyne. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com